Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

2,940 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,940 results

Testing effectiveness (Phase 2)WithdrawnNCT05279859
What this trial is testing

Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
Erasca, Inc.
Post-approval studies (Phase 4)Ended earlyNCT03262142
What this trial is testing

Targeted AntiBiotics for Chronic Pulmonary Diseases

Who this might be right for
COPDRespiratory Tract InfectionsPseudomonas Aeruginosa+2 more
Chronic Obstructive Pulmonary Disease Trial Network, Denmark 51
Not applicableLooking for participantsNCT06231966
What this trial is testing

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

Who this might be right for
Peripheral Artery DiseasePolyvascular Disease
Yonsei University 2,462
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableStudy completedNCT04499846
What this trial is testing

Educational Intervention Targeting Statin Therapy and Compliance in Diabetic Patients

Who this might be right for
Type II Diabetes
Lille Catholic University 96
Testing effectiveness (Phase 2)Looking for participantsNCT07688356
What this trial is testing

Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors

Who this might be right for
Primary Brain TumorMetastatic Brain Tumor
Samsung Medical Center 30
Not applicableUnknownNCT01432002
What this trial is testing

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

Who this might be right for
Breast Neoplasm
University Hospital, Geneva 60
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Early research (Phase 1)Looking for participantsNCT06484556
What this trial is testing

T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

Who this might be right for
Tumor, Solid
Tao Zhang 9
Not applicableEnded earlyNCT04756856
What this trial is testing

Muscle-targeted Nutritional Therapy for the Recovery From COVID-19

Who this might be right for
Sarcopenia
Fondazione IRCCS Policlinico San Matteo di Pavia 5
Not applicableNot Yet RecruitingNCT06694129
What this trial is testing

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

Who this might be right for
Non-Small Cell Lung CancerROS1 Gene RearrangementResistance+1 more
National Cancer Center, China 40
Testing effectiveness (Phase 2)UnknownNCT03896854
What this trial is testing

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 15
Not applicableNot Yet RecruitingNCT07307729
What this trial is testing

AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emulation Study

Who this might be right for
Hyperkalaemia
National Defense Medical Center, Taiwan 5,000
Post-approval studies (Phase 4)UnknownNCT05855577
What this trial is testing

Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients

Who this might be right for
Parkinson DiseaseGait AnalysisTherapy, Directly Observed+1 more
I.R.C.C.S. Fondazione Santa Lucia 50
Not applicableUnknownNCT05609695
What this trial is testing

Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
Sun Yat-sen University 100
Early research (Phase 1)UnknownNCT06027853
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Large-scale testing (Phase 3)UnknownNCT05429684
What this trial is testing

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Who this might be right for
HER2+ Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University 120
Large-scale testing (Phase 3)Enrolling By InvitationNCT05678933
What this trial is testing

AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Who this might be right for
Peripheral T-cell Lymphoma Targeted Therapy
Tianjin Medical University Cancer Institute and Hospital 200
Post-approval studies (Phase 4)UnknownNCT03008083
What this trial is testing

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Who this might be right for
Drug-Eluting StentsPercutaneous Coronary Intervention
Shanghai MicroPort Medical (Group) Co., Ltd. 2,446
Testing effectiveness (Phase 2)UnknownNCT01131429
What this trial is testing

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Neoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more
Chinese PLA General Hospital 60
Next Page